Literature DB >> 12597597

Automated solid-phase extraction method for the determination of piperaquine in plasma by peak compression liquid chromatography.

N Lindegårdh1, M Ashton, Y Bergqvist.   

Abstract

A validated bioanalytical method for the determination of piperaquine (PQ) in plasma by solid-phase extraction (SPE) and liquid chromatography (LC) using peak compression is presented. Protein is precipitated from plasma with acetonitrile-1% aqueous acetic acid (85:15, v/v). An internal standard (IS) is added to the samples before they are loaded onto a strong cation exchanger (Isolute PRS) SPE column. PQ and the IS are analyzed by LC on a Zorbax SB-CN column (250 x 4.0 mm) with the mobile phase acetonitrile-phosphate buffer [I = 0.1, pH 2.5 (12:88, v/v)] and UV detection at 345 nm. Trichloroacetic acid (TCA) is added to the samples prior to injection into the chromatography system. PQ elutes in a gradient of TCA, which enables peak compression of PQ and significantly higher peak efficiency as a result. The intraassay precision for plasma is determined to be 5.4% at 3.00 microM and 5.8% at 0.050 microM. The interassay precision for plasma is 1.3% at 3.00 microM and 10.0% at 0.050 microM. The lower limit of quantitation and the limit of detection are 0.025 and 0.005 microM, respectively.

Mesh:

Substances:

Year:  2003        PMID: 12597597     DOI: 10.1093/chromsci/41.1.44

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  5 in total

Review 1.  Piperaquine: a resurgent antimalarial drug.

Authors:  Timothy M E Davis; Te-Yu Hung; Ing-Kye Sim; Harin A Karunajeewa; Kenneth F Ilett
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects.

Authors:  Daniel Röshammar; Trinh Ngoc Hai; Sofia Friberg Hietala; Nguyen Van Huong; Michael Ashton
Journal:  Eur J Clin Pharmacol       Date:  2006-03-29       Impact factor: 2.953

3.  Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS.

Authors:  Linda L Kjellin; Grant Dorsey; Philip J Rosenthal; Francesca Aweeka; Liusheng Huang
Journal:  Bioanalysis       Date:  2014       Impact factor: 2.681

4.  Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Authors:  Elizabeth A Ashley; Kasia Stepniewska; Niklas Lindegardh; Anna Annerberg; Joel Tarning; Rose McGready; Lucy Phaiphun; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Eur J Clin Pharmacol       Date:  2010-03-19       Impact factor: 2.953

5.  Determination of piperaquine concentration in human plasma and the correlation of capillary versus venous plasma concentrations.

Authors:  Norah Mwebaza; Vincent Cheah; Camilla Forsman; Richard Kajubi; Florence Marzan; Erika Wallender; Grant Dorsey; Philip J Rosenthal; Francesca Aweeka; Liusheng Huang
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.